RxDoctor Payments Data

John Boockvar, MD

Neurological Surgery · Brooklyn, NYNPI 1881651545

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,900 of the $6,593 with a category attached, or 74.3%. Boston Scientific accounts for 77.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $4,900 and has fallen 95.9% since, to $201 in 2025.

$6,593in general payments, 2019–2025

Across 27 payments — averaging $244.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$5K
  • Novocure Inc.$479
  • Longeviti Neuro Solutions Inc$365
  • Stryker$224
  • 4web, Inc.$186
  • GT Medical Technologies, Inc$114
  • plus $106 from 3 others
$217,231in research payments, 2019–2025

Across 44 payments — averaging $4937.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$141K
  • Bristol Myers Squibb$43K
  • Karyopharm Therapeutics Inc.$29K
  • Novartis$5K

What the payments were for

  • Consulting fees$4,90074%
  • Food & beverage$1,69326%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,593 in reported general payments places this provider in the 60th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York

Medicare billing

Part B allowed, 2024
$129,419
Medicare patients
134
Services billed
359

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →